Sign in

    Willis Towers Watson PLC (WTW)

    You might also like

    WTW is a company that operates in two main segments: Health, Wealth & Career (HWC) and Risk & Broking. The company provides a variety of services, including advice, broking, solutions, and technology, aimed at enhancing employee benefit plans, institutional investments, compensation, career programs, and overall employee experience . WTW's offerings are designed to address human resources and risk needs, with a focus on growing revenue, improving margins, and increasing cash flow, EBITDA, and earnings through strategic priorities .

    1. Health, Wealth & Career (HWC) - Offers services such as advice, broking, solutions, and technology for employee benefit plans, institutional investors, compensation and career programs, and overall employee experience. Focuses on key areas like Health, Wealth, Career, and Benefits Delivery & Outsourcing .
    2. Risk & Broking - Provides insurance broking and consulting services, influenced by economic conditions and insurance market cycles .
    Initial Price$274.64April 1, 2024
    Final Price$259.42July 1, 2024
    Price Change$-15.22
    % Change-5.54%

    What went well

    • Strong organic revenue growth in key segments, with Health and Wealth Consulting (HWC) experiencing 9% growth and Corporate Risk and Broking (CRB) achieving 10% growth. The company expects continued momentum due to investments in talent and a differentiated strategy. ,
    • Margin expansion opportunities are present, with potential to outperform the updated 2024 margin guidance of 23% to 23.5%, driven by better-than-expected productivity from talent investments and prudent expense management without impacting growth. ,
    • Improved employee morale and engagement are leading to higher productivity and confidence in executing the company's strategy, contributing to positive momentum across the organization.

    What went wrong

    • Expected slowdown in margin expansion in the second half of the year: Analysts noted a meaningful slowdown in margin expansion expected in H2, questioning why the significant expansion in H1 would not continue. WTW acknowledged this, indicating that while they are optimistic, they expect margins to be similar to prior levels. ( (#7))
    • Tempered demand for discretionary services impacting growth: WTW experienced flat growth in their ICT segment due to tempered demand for discretionary services, with some large consulting projects being postponed. They recognize that the environment for certain advisory work continues to be challenging. ( (#8))
    • Deliberate moderation of growth in Medicare-related businesses affecting free cash flow: WTW intentionally slowed growth in Medicare-related businesses to maximize profitability and improve free cash flow, citing increased media buying costs driven by the U.S. election and resulting consumer distraction. This could impact growth and cash flow in this segment. ( (#9))

    Q&A Summary

    1. Margin Outlook
      Q: What could drive margins above guidance?
      A: Management sees opportunities for stronger margins due to better-than-expected productivity from talent investments, timing of transformation savings, expense trimming without impacting growth, and potential rebounding global M&A activity. They increased margin guidance to 23% to 23.5% for the year and see opportunities to potentially outperform this range.

    2. Organic Growth Sustainability
      Q: Is high organic growth sustainable or one-time?
      A: The strong organic growth is viewed as sustainable, driven by tailwinds like pension de-risking, increased compensation benchmarking, and the specialization strategy. Management expects mid-single-digit or better growth, supported by strong client retention rates and continued investments in talent and technology.

    3. Transformation Savings and Future Efficiencies
      Q: How will transformation savings impact future efficiencies?
      A: As simpler parts of the transformation program conclude, focus shifts to technology modernization and process optimization, yielding efficiencies mostly impacting 2025. Initiatives like cloud migration, centralizing support, and reducing application portfolios aim to simplify operations and drive further efficiencies beyond 2024.

    4. Free Cash Flow Conversion
      Q: Will free cash flow conversion exceed targets post-transformation?
      A: The 16%+ free cash flow margin target is a longer-term goal, not necessarily tied to 2024. Progress is expected through operating margin expansion, reduction of transformation-related cash outlays by early 2025, and improved cash conversion in the TransAct business. These factors combined are anticipated to achieve the target over time.

    5. Transformation Cash Spend
      Q: Will transformation spend decrease and boost free cash flow?
      A: Management indicates that some transformation cash spend will extend into 2025, so the expected reduction may not immediately benefit free cash flow as anticipated.

    6. Medicare Business Growth Moderation
      Q: Why was Medicare business growth deliberately moderated?
      A: Growth in Medicare-related businesses was intentionally slowed to reflect market developments, maximize profitability, and improve free cash flow. Increased media buying costs due to U.S. election activity and consumer distraction influenced this decision. The decrease was offset by solid growth in outsourcing, and the company remains confident in achieving mid-single-digit organic growth for the HWC segment.

    7. Property & Casualty Market Outlook
      Q: What is the outlook for the P&C market and casualty issues?
      A: The P&C market is generally stabilizing to softening. Property trends are stabilizing despite significant natural catastrophe losses. Casualty faces reduced capacity and higher pricing. Financial lines are softening with slower rate reductions. Geographic trends vary, but overall rate changes are not a significant tailwind or headwind to the company's R&B portfolio. Growth is driven by high retention rates, new business, and investments in talent and specialization.

    8. CRB Pricing Across Segments
      Q: How is pricing varying across customer segments in CRB?
      A: Pricing is differentiated based on risk nature and past performance. Catastrophe-exposed property is more challenging than loss-free clients. Markets are differentiating pricing accordingly, but capacity issues from prior years are not present. The company is achieving good results for clients and expects this to continue.

    9. ICT Segment Outlook
      Q: Which ICT services might drive a pickup in the second half?
      A: ICT, representing about $400 million in annual revenue, split between software sales and consulting, saw postponed consulting projects in the first half. They expect mid-single-digit growth, potentially boosted by timing of software sales and consulting projects, though some advisory work remains challenging.

    10. Headcount Growth and Talent Productivity
      Q: Will headcount growth in R&B increase from 2%?
      A: After replenishing the talent base, current hiring is more opportunistic and strategic. New talent cohorts are still maturing to peak productivity. Investments in talent won't hinder hitting the 2024 margin targets, and margin expansion is expected in both segments.

    NamePositionStart DateShort Bio
    Carl A. HessChief Executive OfficerJanuary 1, 2022Carl A. Hess has served as the CEO of WTW since January 1, 2022. He was previously the President from August 16, 2021, and Head of Investment, Risk and Reinsurance from October 27, 2016, to August 16, 2021 .
    Andrew J. KrasnerChief Financial OfficerSeptember 7, 2021Andrew J. Krasner has been the CFO at WTW since September 7, 2021. He was previously the CFO for Assured Partners and held various roles at WTW, including Global Treasurer and Head of M&A .
    Kristy D. BanasChief Human Resources OfficerAugust 16, 2021Kristy D. Banas has been the CHRO at WTW since August 16, 2021. She previously served as Senior Director, Global Talent Advisor for Human Capital & Benefits and held other senior HR roles at WTW .
    Alexis FaberChief Operating OfficerAugust 30, 2021Alexis Faber has been the COO at WTW since August 30, 2021. She was previously the COO for Corporate Risk & Broking and worked in investment banking at Schroder Salomon Smith Barney and Citigroup .
    Matthew S. FurmanGeneral CounselJanuary 4, 2016Matthew S. Furman has served as General Counsel at WTW since January 4, 2016. He was previously EVP and Group General Counsel at Willis Group Holdings and held legal roles at The Travelers Companies and Goldman, Sachs & Co. .
    Adam L. GarrardHead of Risk and BrokingJanuary 1, 2022Adam L. Garrard has been Head of Risk and Broking at WTW since January 1, 2022. He previously served as Head of Corporate Risk and Broking, and International, and held CEO roles for Willis Group Holdings in various regions .
    Julie J. GebauerHead of Health, Wealth and CareerJanuary 1, 2022Julie J. Gebauer has been Head of Health, Wealth and Career at WTW since January 1, 2022. She was previously Head of Human Capital & Benefits and held leadership roles at Towers Watson and Towers Perrin .
    Anne PullumHead of EuropeAugust 30, 2021Anne Pullum has been Head of Europe at WTW since August 30, 2021. She was previously Head of Western Europe and held roles as Chief Administrative Officer and Head of Strategy and Innovation at WTW .
    Imran QureshiHead of North AmericaAugust 30, 2021Imran Qureshi has been Head of North America at WTW since August 30, 2021. He was previously Co-Leader for the U.S. and has held various leadership roles at WTW since March 1999 .
    1. Your Risk & Broking segment achieved organic revenue growth of 10% this quarter, driven by your specialty businesses and increased productivity from new hires . Given that Verita, while growing, is still not contributing significantly to organic growth , how do you plan to sustain this level of growth in R&B, and what specific initiatives are you undertaking to ensure continued outperformance?

    2. With the transformation program's cost savings from this year not expected to have a meaningful impact until 2025 , how do you plan to drive further efficiencies post-2024, and can you detail the specific actions you're implementing now to ensure continued margin expansion beyond the program's conclusion?

    3. You've deliberately moderated growth in your Medicare-related businesses to maximize profitability and improve free cash flow amid increased media buying costs and consumer distraction due to the U.S. elections . How will you navigate these challenges to still achieve your mid-single-digit organic revenue growth target for the Health, Wealth & Career segment, and are there alternative strategies to drive growth without incurring higher acquisition costs?

    4. Unallocated costs increased significantly this quarter, including a $13 million legal provision , but you expect these costs to be similar to 2023 levels for the full year . Can you elaborate on the factors contributing to these unallocated costs and how you plan to manage or reduce them to prevent impacting margins in the second half?

    5. With Lucy Clark joining to lead Risk & Broking, aligning with your focus on specialization and technology , what specific strategic initiatives is she expected to implement in the next 12 to 18 months to enhance growth and profitability, and how will her leadership impact talent acquisition and service differentiation in a competitive market?

    Program DetailsProgram 1
    Approval DateSeptember 20, 2023
    End Date/DurationNo expiration date
    Total additional amount$1.0 billion
    Remaining authorization amount$837 million
    DetailsCan be suspended or discontinued at any time

    Q2 2024 Earnings Call

    • Issued Period: Q2 2024
    • Guided Period: FY 2024
    • Guidance:
      1. Adjusted Operating Margin: Target range of 23.0% to 23.5% .
      2. Adjusted EPS: Target range of $16 to $17 .
      3. Organic Revenue Growth: Mid-single-digit growth to reach $9.9 billion plus .
      4. Transformation Savings: Cumulative run rate target of $450 million by end of 2024 .
      5. Share Repurchases: Approximately $750 million in 2024 .
      6. Free Cash Flow Margin: Long-term target of 16% plus .

    Q1 2024 Earnings Call

    • Issued Period: Q1 2024
    • Guided Period: FY 2024
    • Guidance:
      1. Organic Revenue Growth: Mid-single-digit growth, targeting at least $9.9 billion .
      2. Adjusted Operating Margin: Continued margin expansion .
      3. Free Cash Flow Margin: Year-over-year improvement, long-term target of 16% plus .
      4. Share Repurchases: Approximately $750 million in 2024 .
      5. Interest Expense: Temporary uptick expected .
      6. Adjusted Tax Rate: Close to 2023 rate, excluding one-time items .
      7. Segment-Specific Guidance:
        • HWC: Mid-single-digit growth .
        • R&B: Continued margin expansion .

    Q4 2023 Earnings Call

    • Issued Period: Q4 2023
    • Guided Period: FY 2024
    • Guidance:
      1. EPS Guidance: Adjusted diluted EPS of $15.40 to $17 .
      2. Revenue Growth: Mid-single-digit organic growth, aiming for $9.9 billion-plus .
      3. Operating Margin: Expansion toward high end of 22.5% to 23.5% range .
      4. Share Repurchases: Approximately $750 million in 2024 .
      5. Tax Rate: Close to 2023 adjusted rate, excluding one-time benefits .
      6. Free Cash Flow Margin: Incremental improvement expected .
      7. Pension Income: Expected to be $88 million for 2024 .

    Q3 2024 Earnings Call

    • Issued Period: Q3 2024
    • Guided Period: N/A
    • Guidance: The documents do not contain information about WTW's guidance from the Q3 2024 earnings call. The available information is from the Q2 2024 earnings call.

    Competitors mentioned in the company's latest 10K filing.

    • Aon plc
    • Arthur J. Gallagher & Co.
    • Brown & Brown Inc.
    • Cognizant Technology Solutions Corporation
    • Marsh & McLennan Companies, Inc. ('Marsh & McLennan')
    • Robert Half International Inc.
    • Mercer HR Consulting (a Marsh & McLennan company) - Competitor in the pension consulting industry
    • Milliman - Major competitor in the insurance consulting and software industry
    • Oliver Wyman (a Marsh & McLennan company) - Major competitor in the insurance consulting and software industry
    • Deloitte LLP - Part of the big four accounting firms, competitor in the insurance consulting and software industry
    • Ernst & Young - Part of the big four accounting firms, competitor in the insurance consulting and software industry
    • PricewaterhouseCoopers - Part of the big four accounting firms, competitor in the insurance consulting and software industry
    • KPMG - Part of the big four accounting firms, competitor in the insurance consulting and software industry
    • SunGard - Major competitor in the insurance consulting and software industry
    • Buck Consultants (an HIG Capital Company) - Competitor in the insurance exchange industry
    • Connextions (a United Healthcare company) - Competitor in the insurance exchange industry
    • Automatic Data Processing - Competitor in the insurance exchange industry
    • Fidelity - Competitor in the insurance exchange industry
    • WageWorks - Competitor in account-based health plans and consumer-directed benefits
    • HealthEquity - Competitor in account-based health plans and consumer-directed benefits

    Recent developments and announcements about WTW.

    Financial Reporting

      Auditor Changes

      ·
      Mar 3, 2017, 12:00 AM

      Willis Towers Watson (WTW) Auditor Change

      On March 2, 2017, Willis Towers Watson Public Limited Company (WTW) changed its independent registered public accounting firm from Deloitte LLP (UK) to Deloitte & Touche LLP (US). This decision was approved by the Audit and Risk Committee of the Company's Board of Directors. The change was made to align with the company's key financial leadership, which is now based in the United States. Deloitte LLP (UK) resigned on the same date, and there were no disagreements or reportable events during their tenure .